Matrix Metalloproteinases and Human Papillomavirus in Dysplasias and Cancers of the Cervix

NACompletedINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

October 10, 2007

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Papillomavirus InfectionsDysplasiaCervix Cancer
Interventions
OTHER

Vaginal samples (biopsies + vaginal smear)

Two types of samples are envisaged: tissue (large biopsies, coin of conization or hysterectomy) to affirm the diagnosis and detect the matrix metalloproteinases and their tissue inhibitors by immunohistochemistry; cell sample (monolayer smear type) to evaluate the expression of oncogenic Human papillomavirus.

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT04072913 - Matrix Metalloproteinases and Human Papillomavirus in Dysplasias and Cancers of the Cervix | Biotech Hunter | Biotech Hunter